CD4 and neoplasm: The proportion of CD3+ T cells was similar in all UICC stages and compared to the healthy controls (Figure 3B), whereas the proportion of CD4+ T helper cells was progressively lower in higher tumor stages, with a statistically significant value for stage IV (** p < 0.01, Figure 3C).